GLS and cancer: An example of metabolic inhibitors affecting non-immune cells of TME regards GLS inhibitors, which have been associated with synergistic anti-tumorigenic effects, since apart from suppressing cancer cell survival [137], reduced proangiogenic signals deriving from connective tissue.